Fluticasone
Showing 76 - 100 of 895
Bioequivalence Trial in Larissa (Test Product, Reference Product)
Completed
- Bioequivalence
- Test Product
- Reference Product
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Mar 8, 2021
Asthma Trial in New York (Fluticasone propionate HFA 220)
Completed
- Asthma
- Fluticasone propionate HFA 220
-
New York, New YorkNew York University Langone Medical Center
Sep 10, 2021
COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol
Withdrawn
- COPD
- Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
- Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
- (no location specified)
Jan 19, 2022
Replication of the IMPACT COPD Trial in Healthcare Claims Data
Completed
- COPD
- Fluticasone Furoate-Vilanterol Trifenatate
- Furoate-umeclidinium-vilanterol
-
Boston, MassachusettsBrigham and Women's Hospital
Sep 20, 2021
Asthma Trial in Czechia (Elpenhaler active - Diskus )
Completed
- Asthma
- Elpenhaler active - Diskus placebo
-
Karlovy Vary, Drahovice, Czechia
- +4 more
Apr 8, 2021
Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®
Completed
- Bioequivalence
- Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent
- ADVAIR DISKUS® 500/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Jan 18, 2021
Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent, ADVAIR DISKUS®
Completed
- Bioequivalence
- Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent
- ADVAIR DISKUS® 250/50
-
Larissa, Thessaly, GreeceBECRO Clinical Facility
Jan 18, 2021
Stem Cell Transplant Complications, Respiratory Disease, Bronchiolitis Obliterans Trial in Paris (Seretide, Placebo)
Recruiting
- Stem Cell Transplant Complications
- +2 more
- Seretide
- Placebo
-
Paris, FranceHoudouin véronique
Jun 7, 2021
Rhinitis, Allergic, Seasonal Trial in United States (Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals),
Completed
- Rhinitis, Allergic, Seasonal
- Fluticasone furoate 27.5 mcg/actuation nasal spray (Lek Pharmaceuticals)
- +2 more
-
Austin, Texas
- +6 more
Jan 14, 2021
Allergic Rhinitis Trial (Fluticasone Propionate, Azelastine HCl and fluticasone propionate, Rupatadine)
Unknown status
- Allergic Rhinitis
- Fluticasone Propionate
- +2 more
- (no location specified)
Oct 22, 2020
Obstructive Sleep Apnea Syndrome Trial in Philadelphia (Nasal Fluticasone, Placebo)
Completed
- Obstructive Sleep Apnea Syndrome
- Nasal Fluticasone
- Placebo
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 2, 2021
Asthma Trial in Athens (Fluticasone propionate 100 mcg/blister oral inhalation powder/Respirent Pharmaceuticals, FLOVENT DISKUS®
Recruiting
- Asthma
- Fluticasone propionate 100 mcg/blister oral inhalation powder/Respirent Pharmaceuticals
- +2 more
-
Athens, GreeceBECRO Ltd.
Jan 19, 2021
US Based on Pharmacy and Medical Claims That Compares How Well
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
White Plains, New YorkeMax health
Jan 11, 2022
Asthma Trial in Green Tree, Pittsburgh (Fluticasone, Budesonide, Beclomethasone, Fluticasone, Beclomethasone, Budesonide,
Completed
- Asthma
- Fluticasone, Budesonide, Beclomethasone
- +5 more
-
Green Tree, Pennsylvania
- +1 more
Oct 30, 2020
Asthma in Children Trial in Xi'an (Fluticasone propionate inhaled aerosol)
Not yet recruiting
- Asthma in Children
- Fluticasone propionate inhaled aerosol
-
Xi'an, Shanxi, ChinaDepartment of Pediatrics, Xijing Hospital
Jun 29, 2021
Covid19 Trial in United States (Fluticasone, Placebo)
Completed
- Covid19
- Fluticasone
- Placebo
-
Gilbert, Arizona
- +86 more
Feb 17, 2023
Asthma Trial in Worldwide (Fluticasone Propionate, Fluticasone Propionate/Salmeterol, Placebo MDPI)
Completed
- Asthma
- Fluticasone Propionate
- +2 more
-
Birmingham, Alabama
- +117 more
Nov 5, 2021
Allergic Rhinitis Trial in China (Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT, Azelastine Hydrochloride 0.137
Completed
- Allergic Rhinitis
- Azelastine Hydrochl./Fluticasone Prop. 0.137/0.05 MG/ACTUAT
- +2 more
-
Beijing, Beijing, China
- +32 more
Feb 4, 2022
Blepharitis Trial in Austin (Fluticasone Propionate, Placebo)
Completed
- Blepharitis
- Fluticasone Propionate
- Placebo
-
Austin, TexasTexan Eye
Nov 10, 2020
Seasonal Allergic Rhinitis Trial in Irvine (Bepotastine besilate formulation, Fluticasone propionate, Bepotastine
Completed
- Seasonal Allergic Rhinitis
- Bepotastine besilate formulation
- +3 more
-
Irvine, CaliforniaISTA Pharmaceuticals, Inc.
Oct 1, 2020
Wheezy Bronchitis, Asthmatic Bronchitis, Wheezing Trial in Helsinki (Tiotropium Bromide, Fluticasone Propionate, Salbutamol)
Completed
- Wheezy Bronchitis
- +3 more
- Tiotropium Bromide
- +2 more
-
Helsinki, FinlandSkin and Allergy Hospital, Helsinki University Hospital, Helsink
Feb 13, 2021